Single-target CRISPR Detection Device

Rapid CRISPR-based detection test strip for molecular diagnostics. Enables quick visual detection of nucleic acid targets.

An innovative molecular detection platform utilizing microfluidic PCR technology capable of completing nucleic acid rapid detection within 30 minutes with high sensitivity and high specificity. The reagents are stable at room temperature without requiring cold chain storage, support customized multiplex detection, and can simultaneously detect up to 48 targets, providing an efficient solution for multi-pathogen detection.

Molecular detection devices and microfluidic systems for point-of-care and in vitro diagnostic testing. The company manufactures molecular detection components and related disposable consumables using precision molding, injection molding, laser processing, and assembly techniques. ISO 13485 certified for medical device production with capabilities spanning prototyping through large-scale manufacturing.

Point-of-care testing system for molecular detection applications. Enables rapid on-site diagnosis with molecular-level precision for clinical or field testing.

A portable point-of-care molecular detection system designed for rapid nucleic acid testing outside traditional laboratory environments. The solution enables on-site molecular diagnostics with minimal sample preparation.

Single-use rapid detection card or cup for on-site substance and biomarker screening. Designed for point-of-care testing with visual readout and rapid result interpretation.

Molecular diagnostics platform for infectious disease identification and confirmation. Utilizes proprietary technology for rapid and accurate pathogen detection.

An advanced molecular medicine platform providing fast and precise detection of genetic markers and disease indicators. The technology addresses unmet clinical needs in genetic disease screening and diagnosis.

Infectious disease detection kits utilizing microfluidic chip, fluorescence quantitative PCR, and isothermal amplification technologies for rapid pathogen identification and diagnosis. Designed for epidemic screening, disease diagnosis, and clinical monitoring across multiple infectious disease applications.

Point-of-care multiplex nucleic acid detection system enabling rapid syndromic molecular testing at or near the patient location. Delivers sample-to-answer results for pathogen identification, supporting faster clinical decision-making in emergency, urgent care, and primary care settings. Integrates multiple targets in a single automated assay workflow.

Molecular diagnostic test using CRISPR/Cas9 technology to identify and amplify mutant DNA sequences in patient samples. Provides standardized detection and quantification of cancer-related genetic mutations.

Microfluidic diagnostic chips for biochemical analysis and detection in clinical and research laboratories.